ARCHIVES

Analysis Shows No Mortality Benefit From Regular PSA Screening

This article is from The Cancer Letter archive.

Vol. 35 No. 1 | January 27, 2012

Download PDF Visit The Full Archive

Related Articles

FDA Accepts Advisory Committee’s Recommendations On NDA, Labeling

October 26, 1979

In Brief: CTEP Files IND For Antineoplaston, Mayo, MSK, Plan Trials; Researcher Escapes Bosnia

August 6, 1993

In Brief: Barry Pierce New DCCP Chairman; Adamson Seeks Ads For Chemical, Biological Carcinogenesis

June 17, 1983

Phase III Ramucirumab Trial Fails Primary Endpoint of PFS

October 25, 2013

Bush Administration proposes 2.7 percent increase for NIH in fiscal year 2005; NIH budgets listed by institute.

February 6, 2004

Murphy Puts RPMI On Record

July 22, 1977